# The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

> **NCT04351347** · PHASE2,PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 300 (estimated)

## Conditions studied

- COVID

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT04351347
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-06-16
- **Primary completion:** 2030-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04351347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04351347, "The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04351347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*